K[Ru(TFA)3(CO)3] | 1147124-76-2

• 英文名称: K[Ru(TFA)3(CO)3]
• 英文别名: potassium [Ru(trifluoroaceto)3(CO)3]；K[Ru(trifluoroacetate)3(CO)3]
• CAS: 1147124-76-2
• 化学式: C₉F₉O₉Ru*K
• 分子量: 563.248
• InChiKey: IPQATNQBNGNZDA-UHFFFAOYSA-K

计算性质

• 辛醇/水分配系数(LogP)：
  None
• 重原子数：
  None
• 可旋转键数：
  None
• 环数：
  None
• sp3杂化的碳原子比例：
  None
• 拓扑面积：
  None
• 氢给体数：
  None
• 氢受体数：
  None

反应信息

• 作为反应物：
  描述：

  K[Ru(TFA)3(CO)3] 、 二甲基苯基磷 以 丙酮 为溶剂， 反应 24.0h， 以27%的产率得到
  参考文献：
  名称：

  Ru(TFA)(CO)(PPh3)2(L)（L=2-苯基吡啶、2-对甲苯基吡啶）和Ru(CO)(PPhMe2)2(L)(L的合成、结构、光物理和电化学性质') (L= TFA, H) (L'= 联吡啶, L'= 4,4'-二甲基联吡啶) 辅助配体结构与发光特性之间的关系。

  摘要：

  配合物[Ru[(CO)(TFA) (PPh 3 ) 2 (L)][(L = ppy = 2-苯基吡啶, ( 1a ); L = 2–(p–tolyl)的合成、结构和光物理性质）报道了[Ru(CO)( )吡啶] ( 1b )。配合物通过UV-VIS、IR和NMR以及单晶X射线衍射技术进行了表征。我们还报道了[Ru(CO)( L)(PPhMe 2 ) 2 (L′)] + [PF 6 ] − [L′ = 联吡啶，L = TFA，( 3a )；L = H，( 3b ) 且 L = H，L′ = 4,4 '-二甲基联吡啶 ( 3c )]。这些化合物通过 UV-VIS、IR 和 NMR 技术进行了表征，在3a的情况下通过单晶 X 射线衍射进行了表征。[Ru(Me 2 PhP) 2的固态结构(CO) 2 (TFA) 2 (2)是合成3a - 3c的起始材料，也被报道用于验证体积较小的 PPhMe 2的反式关系，并与之前报道的

  DOI：

  10.1016/j.jorganchem.2017.03.026
• 作为产物：
  描述：

  三氟乙酸 、 十二羰基三钌 在 potassium carbonate 作用下， 以 三氟乙酸 为溶剂， 生成 K[Ru(TFA)3(CO)3]
  参考文献：
  名称：

  Rosenberg, Edward; Skinner, David M.; Aime, Silvio, Gazzetta Chimica Italiana, 1991, vol. 121, p. 313 - 320

  摘要：

  DOI：

文献信息

• Tuning photophysical properties with ancillary ligands in Ru(II) mono-diimine complexes
  作者：Ayesha Sharmin、Reuben C. Darlington、Kenneth I. Hardcastle、Mauro Ravera、Edward Rosenberg、J.B. Alexander Ross

  DOI：10.1016/j.jorganchem.2008.11.048

  日期：2009.3

  the neutral complex Ru(Ph3P)(CO)(1,10-phenanthroline)(TFA)2 is also obtained and its solid state structure is reported. Solid state structures are also reported for the cationic complexes where L–L = phenanthroline, L2 = 2PPh3 and X = Cl and for L–L = 2,2′-bipyridyl, L2 = 2PPh3 and X = H. All the complexes were characterized in solution by a combination of 1H and 31P NMR, IR, mass spectrometry and elemental

  系列配合物 [XRu(CO)(L–L)(L′) 2 ][PF 6 ] (X = H, TFA, Cl; L–L = 2,2′-联吡啶，1,10-菲咯啉， 5-氨基-1,10-菲咯啉和4,4'-二羧基-2,2'-联吡啶; L' 2  = 2PPh 3 , Ph 2 PC 2 H 4 PPh 2 , Ph 2 PCH CHPPh 2 ) 已由以下合成首先与膦配体反应，然后与 L–L 反应并与 NaPF 6进行阴离子交换，得到起始配合物 K[Ru(CO) 3 (TFA) 3 ] (TFA = CF 3 CO 2 ) 。在L–L = 菲咯啉和L′ 2  = 2PPh 3的情况下，还获得了中性配合物Ru(Ph 3 P)(CO)(1,10-菲咯啉)(TFA) 2并报道了其固态结构。还报告了阳离子配合物的固态结构，其中 L–L = 菲咯啉，L 2  = 2PPh 3和 X = Cl，对于 L–L = 2
• Photophysical Studies of Bioconjugated Ruthenium Metal–Ligand Complexes Incorporated in Phospholipid Membrane Bilayers
  作者：Ayesha Sharmin、Luca Salassa、Edward Rosenberg、J. B. Alexander Ross、Geoffrey Abbott、Labe Black、Michelle Terwilliger、Robert Brooks

  DOI：10.1021/ic400706u

  日期：2013.10.7

  The luminescent, mono-diimine ruthenium complexes [(H)Ru(CO)(PPh3)(2)(dcbpy)][PF6] (1) (dcbpy = 4,4'-dicarboxy-2,2'-bipyridyl) and [(H)Ru(CO)(dppene)(5-amino-1,10-phen)][PF6] (2) (dppene = bis(diphenylphosphino)ethylene; phen = phenanthroline) were conjugated with 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (DPPE) and with cholesterol in the case of complex 2. Using standard conjugation techniques, compound 1 gives the bis-lipid derivative [(H)Ru(CO)(PPh3)(2)(dcbpy-N-DPPE2)][PF6] (3), while 2 provides the monolipid conjugate [(H)Ru(CO)(dppene)(1,10-phen-5-NHC(S)-N-DPPE)][PF6] (4) and the cholesterol derivative [(H)Ru(CO)(dppene)(1,10-phen-5-NHC(O)Ocholesteryl)][PF6] (5). These compounds were characterized by spectroscopic methods, and their photophysical properties were measured in organic solvents. The luminescence of lipid conjugates 3 and 4 is quenched in organic solvents while compound 4 shows a weak, short-lived, blue-shifted emission in aqueous solution. The cholesterol conjugate 5 shows the long-lived, microsecond-time scale emission associated with triplet metal-to-ligand charge-transfer excited states. Incorporation of conjugate 3 in lipid bilayer vesicles restores the luminescence, but with blue shifts (similar to 80 nm) accompanied by nanosecond-time scale lifetimes. In the vesicles conjugate 4 shows a short-lived and blue-shifted emission similar to that observed in solution but with increased intensity. Conjugation of the complex [(H)Ru(CO)(PhP2C2H4C(O)O-N-succinimidyl)(2)(bpy)][PF6] (6 '') (bpy = 2,2'-bipyridyl) with DPPE gives the phosphine-conjugated complex [(H)Ru(CO)(PhP2C2H4C(O)-N-DPPE)(2)(bpy)][PF6] (7). Complex 7 also exhibits a short-lived and blue-shifted emission in solution and in vesicles as observed for complexes 3 and 4. We have also conjugated the complex [Ru(bpy)(2)(5-amino-1,10-phen)][PF6](2) (8) with both cholesterol (9) and DPPE (10). Neither complex 9 nor the previously reported complex 10 exhibited the blue shifts observed for complexes 3 and 4 when incorporated into large unilamellar vesicles (LUVs). The anisotropies of the emissions of complexes 3, 4, and 7 were also measured in LUVs, and those of complex 5 were measured in both glycerol and LUVs. High fundamental anisotropies were observed for complexes 3, 4, and 7.